Zhejiang Huahai Pharmaceutical Co., Ltd.
600521
주식 순위
#4296
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
주가
$2.42
시가총액
$3.62B
변동 (1일)
-3.06%
변동 (1년)
-8.97%
국가
CN
거래 Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
카테고리
Healthcare
Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)의 주가 이력
최고 종가: $2.43 (2026-10-01 기준)
최저 종가: $0.16 (2003-03-01 기준)
최저 종가: $0.16 (2003-03-01 기준)
Zhejiang Huahai Pharmaceutical Co., Ltd.의 주가 이력 (2003 ~ 2026)
연간 주가 성과
| 연도 | 성과 |
|---|---|
| 2026 (TTM) | -3.88% |
| 2025 | -2.54% |
| 2024 | 21.89% |
| 2023 | -28.55% |
| 2022 | -8.10% |
| 2021 | -38.22% |
| 2020 | 124.56% |
| 2019 | 37.85% |
| 2018 | -48.65% |
| 2017 | 30.46% |
| 2016 | 14.37% |
| 2015 | 53.29% |
| 2014 | 11.91% |
| 2013 | 64.45% |
| 2012 | -5.96% |
| 2011 | -12.19% |
| 2010 | 9.52% |
| 2009 | 102.34% |
| 2008 | -28.32% |
| 2007 | 82.10% |
| 2006 | 48.93% |
| 2005 | -14.60% |
| 2004 | 67.52% |
| 2003 | 0.00% |
유사 기업 또는 경쟁사의 주가
| 회사 | 주가 | 변동률 1년% | 국가 |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
